Abstract
This paper studies the contribution of the workplace to the SES-health gradient. Our analysis is based on a unique dataset that tracks various health outcomes and workplace risks among healthcare workers during the first four months of the coronavirus 2019 (COVID-19) pandemic. The setting provides an exceptional opportunity to test for work-related disparities in health, while controlling for confounding determinants of the SES-health gradient. We find that low-SES nurses were systematically more likely to contract COVID-19 as a result of workplace exposure. These differentials existed in all healthcare institutions, but were particularly large in non-hospital settings. In contrast, we find no relationship between SES and non work-related infection rates. The differences in workplace infection rates are substantially larger than those implied by standard ‘task-based’ indices of transmission risk, and cannot be attributable to easily identifiable metrics of workplace risk. Together, our results show how subtle differences in work conditions or job duties can substantially contribute to the SES-health gradient.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Social Sciences and Humanities Research Council of Canada Grant Number 430-2020-00775
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Comité d’éthique de la recherche en sciences et en santé (CERSES), Université de Montréal: CERSE-2020-067-D
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
(email: raphael.godefroy{at}umontreal.ca), (email: joshua.lewis{at}umontreal.ca).
We thank Marcella Alsan, Gustavo Bobonis, Abel Brodeur, Fabian Lange, Mark Stabile, and seminar partic-ipants at Université de Montréal for valuable comments and suggestions. Financial support from the Social Sciences and Research Council of Canada is gratefully acknowledged. Data can be obtained through an application process to the CIUSSS and the CISSS for the Greater Montreal Area.
Data Availability
Data for the study can be obtained through an application process to the CIUSSS and the CISSS for the Greater Montreal Area.